Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

GenetiVision Corporation
Profile last edited on: 12/3/2019      CAGE: 5HKB0      UEI: DCR3JT98KGB7

Business Identifier: Drosophila genetics
Year Founded
2006
First Award
2012
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

8874 Interchange Drive
Houston, TX 77054
   (713) 502-8502
   info@genetivision.com
   www.genetivision.com
Location: Single
Congr. District: 09
County: Harris

Public Profile

Structured around research experience and expertise in the field of conducting Drosophila genetics, Genetivision addresses dependable production of transgenic flies at low cost so that laboratories are encouraged by the cost savings to outsource this work to the firm. By xtentsionthe firm also provides the superior form of technical support possible only from investigators who are currently conducting Drosophila genetics. Principals of firmnot only work as investigators in Drosophila genetics and currently have active and well-funded laboratories at Baylor College of Medicine in the Texas Medical Center enabling the most up-to-dateness of the latest technological developments. F

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
3
Conversion Rate
100.00%
Phase I Dollars
$417,346
Phase II Dollars
$4,735,027
Total Awarded
$5,152,373

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $1,824,506
Project Title: A Conditional Loss-of-Function Mutation Collection in Drosophila
2018 2 NIH $1,767,385
Project Title: Toward a Complete Set of Germline Null and Modifiable Mutations in Drosophila
2014 2 NIH $2,491,359
Project Title: A New Tool Kit for Whole-Genome Mapping and Complementation in Drosophila

Key People / Management

  Rui Chen -- Co-Founder

  Ming Fa

  Graeme Mardon -- Co-Founder

  Ying Tan

Company News

There are no news available.